Skip to content
777 Sourcing.

Capability

bispecific therapy development

Suppliers
1
States & provinces
1
Countries
1

1 bispecific therapy development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

IMMUNOCORE COMMERCIAL LLC

CONSHOHOCKEN, PA

Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world's first approved T cell receptor (TCR) therapy. Built on its proprietary ImmTAX platform, it develops bispecific therapies for cancer, infectious diseases, and autoimmune diseases, including multiple cancers, HIV and HBV.

biomanufacturingclinical developmentCMC developmentT cell receptor (TCR) therapy discovery and development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list bispecific therapy development.

Browse all capabilities